Co-administration of bisphosphonates has been shown to retard the rate of bone loss in corticosteroid-treated males and post-menopausal females, and these agents are recommended in the prevention and treatment of corticosteroid-induced osteoporosis
Our approach is designed to deliver NAD+ directly, without relying on the body to convert precursors.* Rho's liposomal NAD+ is an oral supplement designed for convenient, at-home use
That does not make all compounding inappropriate, but it does make it a different category with different assumptions and risks
Billon C, Sitaula S, Banerjee S, Welch R, Elgendy B, Hegazy L, et al
Many genes or molecules have been identified to play pivotal roles in the regulation of APAP hepatotoxicity, so they are suggested to be potential targets for therapeutic intervention against APAP-induced liver injury